Ingvar Ferby
Researcher at Department of Immunology, Genetics and Pathology; Research programme: Vascular Biology; Research group Taija Mäkinen
- E-mail:
- ingvar.ferby@igp.uu.se
- Visiting address:
- Rudbecklaboratoriet
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
Biography
My expertise lies in the exploration of cell signalling. I received my PhD at EMBL (European Molecular Biology Laboratory) in Heidelberg, identifying two novel cell cycle regulators, Ringo and Xkid, in the group of Angel Nebreda. At the Max-Planck Institute in Munich, I worked as a postdoc with Rudiger Klein exploring the spatiotemporal control of EGF receptor (EGFR) signaling by generating mice lacking the EGFR feedback inhibitor Mig6. In recent years, my group has first at UCL in London, then at the Ludwig Institute for Cancer Research and now the University in Uppsala, we have broadened our exploration of the spatiotemporal regulation the EGFR and its importance for epithelial homeostasis and development of cancer to also encompass uncovering roles of theses receptors in establishing cell polarity and cell-cell adhesion.

Publications
Recent publications
Lymphatic malformations: mechanistic insights and evolving therapeutic frontiers
Part of Journal of Clinical Investigation, 2024
- DOI for Lymphatic malformations: mechanistic insights and evolving therapeutic frontiers
- Download full text (pdf) of Lymphatic malformations: mechanistic insights and evolving therapeutic frontiers
Part of Cell Reports, p. 1278-1289, 2018
- DOI for The Tumor Suppressor MIG6 Controls Mitotic Progression and the G2/M DNA Damage Checkpoint by Stabilizing the WEE1 Kinase
- Download full text (pdf) of The Tumor Suppressor MIG6 Controls Mitotic Progression and the G2/M DNA Damage Checkpoint by Stabilizing the WEE1 Kinase
Part of Journal of Biological Chemistry, p. 32922-32931, 2013
Part of Developmental Cell, p. 547-559, 2012
All publications
Articles in journal
Lymphatic malformations: mechanistic insights and evolving therapeutic frontiers
Part of Journal of Clinical Investigation, 2024
- DOI for Lymphatic malformations: mechanistic insights and evolving therapeutic frontiers
- Download full text (pdf) of Lymphatic malformations: mechanistic insights and evolving therapeutic frontiers
Part of Cell Reports, p. 1278-1289, 2018
- DOI for The Tumor Suppressor MIG6 Controls Mitotic Progression and the G2/M DNA Damage Checkpoint by Stabilizing the WEE1 Kinase
- Download full text (pdf) of The Tumor Suppressor MIG6 Controls Mitotic Progression and the G2/M DNA Damage Checkpoint by Stabilizing the WEE1 Kinase
Part of Journal of Biological Chemistry, p. 32922-32931, 2013
Part of Developmental Cell, p. 547-559, 2012